regulation Sevi Firat, Founding Partner of Firat Izgi discusses the legal challenges facing pharmaceutical companies looking to penetrate the healthcare market in Turkey, the evolution of the legal landscape and her expectations for the industry’s future. With pricing and regulations as the major challenges facing players within the Turkish pharma and…
local The owner of an indigenous producer and contract manufacturer explains the plethora of new opportunities unfolding for customized industrial batch manufacturing and the impact that EU accession had on the local pharma manufacturing industry. How has domestic pharmaceutical production evolved in Romania? One of the landmark moments for Romanian pharmaceutical production…
local company Turkey’s leading pharmaceutical company is in the process of developing production facilities abroad, and it has just begun construction of a USD 100 million biotech facility; CEO Süha Taşpolatoğlu believes that these two steps will help bring the company closer to its aspiration of becoming a pharmaceutical player on the…
manufacturing Polifarma is Turkey’s largest producer of basic parenteral IV solutions with a 41 percent market share the country and growing exports across the region. According to the Chairman and CEO Ufuk Kumrulu, the company is expanding into medicated hospital solutions, and is aiming to become a “market leader in hospital…
generics Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded generic market and their plans for growth in the future. You are currently the Vice President of CAPGEN; could you please tell us a bit about…
Monash University Professor Kenneth K. C. Lee, Head of the School of Pharmacy at Monash University Malaysia, discusses the institution’s position as a hub for health economics in the Asia Pacific region and explains the factors that will make the university a pharmaceutical leader. There is a lot of competition in…
pricing Cho Chan-Hwui, president of the Korean Pharmaceutical Association (KPA), discusses the major hurdles that pharmacists in Korea must overcome today, and the increased focus on prescription by INN. How successfully has the policy stipulating the separation of prescription and dispensing (SPD) worked over the last 15 years? Complete success…
family business President of the company, Alberto Alvarez-Saavedra, discusses the company’s transformation into a professional organization, and the strategy which has driven remarkable growth in recent years, and will continue to do so as they expand across the region. What have been your main achievements since you took over as the President of…
innovation Recognizing the value of innovation is fundamental for the success of every pharmaceutical company operating in Korea. Lee Sang-Suk, CEO of the Korean Research-based Pharmaceutical industry Association (KRPIA), demonstrates the commitment of multinationals to Korea to help illustrate the benefits of innovation that Koreans can access. What is…
regulation The Indian joint secretary for commerce and industry, interviewed at CPhI Worldwide 2014 in Paris, discusses India’s place in the global pharmaceutical landscape, and emphasizes the country’s contribution to the world’s health. India has gone to great lengths at this CPhI conference to brand itself and show the world…
compliance The president of CETIFARMA, the council created by the pharmaceutical industry in Mexico for ethics and transparency, discusses the tireless effort it has made to professionalize the compliance function in the industry as well as the growing importance of transparency and ethics in its relation with physicians and patients. …
Sanofi The director general of the Argentina, Uruguay and Paraguay region for Sanofi discusses the strength of the Argentinian healthcare system and the key, but subdued, role that multinational pharmaceutical companies play within it. As someone who comes from abroad, how would you describe the environment here for multinationals?…
See our Cookie Privacy Policy Here
